Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1961 1
1962 2
1963 1
1965 7
1966 4
1967 2
1968 2
1969 4
1970 3
1971 2
1972 5
1973 2
1974 7
1975 2
1976 4
1977 4
1978 8
1979 9
1980 12
1981 16
1982 12
1983 13
1984 6
1985 11
1986 22
1987 13
1988 8
1989 17
1990 15
1991 14
1992 18
1993 15
1994 12
1995 20
1996 22
1997 18
1998 19
1999 17
2000 11
2001 13
2002 14
2003 17
2004 37
2005 44
2006 50
2007 54
2008 51
2009 51
2010 45
2011 33
2012 48
2013 43
2014 60
2015 47
2016 39
2017 42
2018 36
2019 38
2020 50
2021 52
2022 36
2023 39
2024 15

Text availability

Article attribute

Article type

Publication date

Search Results

1,207 results

Results by year

Filters applied: . Clear all
Page 1
Genetics of taste receptors.
Bachmanov AA, Bosak NP, Lin C, Matsumoto I, Ohmoto M, Reed DR, Nelson TM. Bachmanov AA, et al. Among authors: matsumoto i. Curr Pharm Des. 2014;20(16):2669-83. doi: 10.2174/13816128113199990566. Curr Pharm Des. 2014. PMID: 23886383 Free PMC article. Review.
Randomized phase II/III trial of neoadjuvant chemotherapy with gemcitabine and S-1 versus upfront surgery for resectable pancreatic cancer (Prep-02/JSAP05).
Motoi F, Kosuge T, Ueno H, Yamaue H, Satoi S, Sho M, Honda G, Matsumoto I, Wada K, Furuse J, Matsuyama Y, Unno M; Study Group of Preoperative Therapy for Pancreatic Cancer (Prep) and Japanese Study Group of Adjuvant Therapy for Pancreatic cancer (JSAP). Motoi F, et al. Among authors: matsumoto i. Jpn J Clin Oncol. 2019 Feb 1;49(2):190-194. doi: 10.1093/jjco/hyy190. Jpn J Clin Oncol. 2019. PMID: 30608598 Clinical Trial.
Single-Cell Transcriptomics Reveals a Conserved Metaplasia Program in Pancreatic Injury.
Ma Z, Lytle NK, Chen B, Jyotsana N, Novak SW, Cho CJ, Caplan L, Ben-Levy O, Neininger AC, Burnette DT, Trinh VQ, Tan MCB, Patterson EA, Arrojo E Drigo R, Giraddi RR, Ramos C, Means AL, Matsumoto I, Manor U, Mills JC, Goldenring JR, Lau KS, Wahl GM, DelGiorno KE. Ma Z, et al. Among authors: matsumoto i. Gastroenterology. 2022 Feb;162(2):604-620.e20. doi: 10.1053/j.gastro.2021.10.027. Epub 2021 Oct 23. Gastroenterology. 2022. PMID: 34695382 Free PMC article.
AXL confers intrinsic resistance to osimertinib and advances the emergence of tolerant cells.
Taniguchi H, Yamada T, Wang R, Tanimura K, Adachi Y, Nishiyama A, Tanimoto A, Takeuchi S, Araujo LH, Boroni M, Yoshimura A, Shiotsu S, Matsumoto I, Watanabe S, Kikuchi T, Miura S, Tanaka H, Kitazaki T, Yamaguchi H, Mukae H, Uchino J, Uehara H, Takayama K, Yano S. Taniguchi H, et al. Among authors: matsumoto i. Nat Commun. 2019 Jan 16;10(1):259. doi: 10.1038/s41467-018-08074-0. Nat Commun. 2019. PMID: 30651547 Free PMC article.
JNETS clinical practice guidelines for gastroenteropancreatic neuroendocrine neoplasms: diagnosis, treatment, and follow-up: a synopsis.
Ito T, Masui T, Komoto I, Doi R, Osamura RY, Sakurai A, Ikeda M, Takano K, Igarashi H, Shimatsu A, Nakamura K, Nakamoto Y, Hijioka S, Morita K, Ishikawa Y, Ohike N, Kasajima A, Kushima R, Kojima M, Sasano H, Hirano S, Mizuno N, Aoki T, Aoki T, Ohtsuka T, Okumura T, Kimura Y, Kudo A, Konishi T, Matsumoto I, Kobayashi N, Fujimori N, Honma Y, Morizane C, Uchino S, Horiuchi K, Yamasaki M, Matsubayashi J, Sato Y, Sekiguchi M, Abe S, Okusaka T, Kida M, Kimura W, Tanaka M, Majima Y, Jensen RT, Hirata K, Imamura M, Uemoto S. Ito T, et al. Among authors: matsumoto i. J Gastroenterol. 2021 Nov;56(11):1033-1044. doi: 10.1007/s00535-021-01827-7. Epub 2021 Sep 29. J Gastroenterol. 2021. PMID: 34586495 Free PMC article.
Intestinal epithelial tuft cells initiate type 2 mucosal immunity to helminth parasites.
Gerbe F, Sidot E, Smyth DJ, Ohmoto M, Matsumoto I, Dardalhon V, Cesses P, Garnier L, Pouzolles M, Brulin B, Bruschi M, Harcus Y, Zimmermann VS, Taylor N, Maizels RM, Jay P. Gerbe F, et al. Among authors: matsumoto i. Nature. 2016 Jan 14;529(7585):226-30. doi: 10.1038/nature16527. Nature. 2016. PMID: 26762460 Free PMC article.
Adjuvant chemotherapy of S-1 versus gemcitabine for resected pancreatic cancer: a phase 3, open-label, randomised, non-inferiority trial (JASPAC 01).
Uesaka K, Boku N, Fukutomi A, Okamura Y, Konishi M, Matsumoto I, Kaneoka Y, Shimizu Y, Nakamori S, Sakamoto H, Morinaga S, Kainuma O, Imai K, Sata N, Hishinuma S, Ojima H, Yamaguchi R, Hirano S, Sudo T, Ohashi Y; JASPAC 01 Study Group. Uesaka K, et al. Among authors: matsumoto i. Lancet. 2016 Jul 16;388(10041):248-57. doi: 10.1016/S0140-6736(16)30583-9. Epub 2016 Jun 2. Lancet. 2016. PMID: 27265347 Clinical Trial.
Self-Assembly of Nanographenes.
Matsumoto I, Sekiya R, Haino T. Matsumoto I, et al. Angew Chem Int Ed Engl. 2021 Jun 1;60(23):12706-12711. doi: 10.1002/anie.202101992. Epub 2021 Apr 12. Angew Chem Int Ed Engl. 2021. PMID: 33689195
Activation mechanisms of monocytes/macrophages in adult-onset Still disease.
Tsuboi H, Segawa S, Yagishita M, Toko H, Honda F, Kitada A, Miki H, Ohyama A, Hagiwara S, Kondo Y, Matsumoto I, Sumida T. Tsuboi H, et al. Among authors: matsumoto i. Front Immunol. 2022 Aug 26;13:953730. doi: 10.3389/fimmu.2022.953730. eCollection 2022. Front Immunol. 2022. PMID: 36090971 Free PMC article. Review.
Induction of Chirality on Nanographenes.
Arimura S, Matsumoto I, Nishitani S, Sekiya R, Haino T. Arimura S, et al. Among authors: matsumoto i. Chem Asian J. 2023 Jun 1;18(11):e202300126. doi: 10.1002/asia.202300126. Epub 2023 Apr 25. Chem Asian J. 2023. PMID: 37032525
1,207 results